SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001214659-17-002021
Filing Date
2017-03-16
Accepted
2017-03-16 16:23:39
Documents
5
Effectiveness Date
2017-03-16

Document Format Files

Seq Description Document Type Size
1 s316174defa14a.htm DEFA14A 25859
2 notice1.jpg GRAPHIC 144873
3 notice2.jpg GRAPHIC 239994
4 notice3.jpg GRAPHIC 114387
5 notice4.jpg GRAPHIC 21261
  Complete submission text file 0001214659-17-002021.txt   744105
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34637 | Film No.: 17694859
SIC: 2834 Pharmaceutical Preparations